Cipla’s fourth-quarter performance shows a sharp decline in profit amid weaker demand in the United States and higher operating outlays. Multiple outlets report that consolidated net profit falls about 54.6% to around ₹555 crore (₹5.55 billion) year-over-year. The company’s revenue from operations declines as well, dropping about 2.8% to ₹6,541 crore, which is described as below market expectations cited by one outlet (average estimate of ₹6,749 crore). Several reports attribute the profit contraction to a drag from key U.S. products, alongside intense competition and weaker sales in the U.S. In addition, one source highlights higher research and development spending and rising operating costs as contributing factors. Overall, the coverage aligns on the magnitude of the profit decline and the role played by U.S. weakness, while also pointing to cost pressures and investment in R&D during the quarter. The reports collectively describe a Q4 marked by lower topline performance and margin impact linked to the U.S. market.